Martin P, Talabot-Ayer D, Seemayer CA, Vigne S, Lamacchia C, Rodriguez E, Finckh A, Smith DE, Gabay C, Palmer G: Disease severity in K/BxN serum transfer-induced arthritis is not affected by IL-33 deficiency. Arthritis Res Ther. 2013, 15: R13-10.1186/ar4143.
Article
PubMed Central
CAS
PubMed
Google Scholar
Smith DE: The biological paths of IL-1 family members IL-18 and IL-33. J Leukoc Biol. 2011, 89: 383-392. 10.1189/jlb.0810470.
Article
CAS
PubMed
Google Scholar
Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S: IL-33 and IL-33 receptors in host defense and diseases. Allergol Int. 2010, 59: 143-160. 10.2332/allergolint.10-RAI-0186.
Article
CAS
PubMed
Google Scholar
Meisel C, Bonhagen K, Löhning M, Coyle AC, Guttierez-Ramos JC, Radbruch A, Kamradt T: Regulation and function of T1/ST2-expression on CD4+ T cells: induction of type 2 cytokine production by T1/ST2-crosslinking. J Immunol. 2001, 166: 3143-3150.
Article
CAS
PubMed
Google Scholar
Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, Finckh A, Smith DE, Gabay C: Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum. 2009, 60: 738-749. 10.1002/art.24305.
Article
CAS
PubMed
Google Scholar
Xu D, Jiang HR, Kewin P, Li Y, Mu R, Fraser AR, Pitman N, Kurowska-Stolarska M, McKenzie AN, McInnes IB, Liew FY: IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci USA. 2008, 105: 10913-10918. 10.1073/pnas.0801898105.
Article
PubMed Central
CAS
PubMed
Google Scholar
Zaiss MM, Kurowska-Stolarska M, Böhm C, Gary R, Scholtysek C, Stolarski B, Reilly J, Kerr S, Millar NL, Kamradt T, McInnes IB, Fallon PG, David JP, Liew FY, Schett G: IL-33 shifts the balance from osteoclast to alternatively activated macrophage differentiation and protects from TNF-alpha-mediated bone loss. J Immunol. 2011, 186: 6097-6105. 10.4049/jimmunol.1003487.
Article
CAS
PubMed
Google Scholar
Xu D, Jiang HR, Li Y, Pushparaj PN, Kurowska-Stolarska M, Leung BP, Mu R, Tay HK, McKenzie AN, McInnes IB, Melendez AJ, Liew FY: IL-33 exacerbates autoantibody-induced arthritis. J Immunol. 2010, 184: 2620-2626. 10.4049/jimmunol.0902685.
Article
CAS
PubMed
Google Scholar
Anthony RM, Kobayashi T, Wermeling F, Ravetch JV: Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway. Nature. 2011, 475: 110-113. 10.1038/nature10134.
Article
PubMed Central
CAS
PubMed
Google Scholar
Holmdahl R, Malissen B: The need for littermate controls. Eur J Immunol. 2012, 42: 45-47. 10.1002/eji.201142048.
Article
CAS
PubMed
Google Scholar
Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O'Neill LA, Liew FY: ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance. Nat Immunol. 2004, 5: 373-379. 10.1038/ni1050.
Article
CAS
PubMed
Google Scholar
Kamradt T, Schubert D: The role and clinical implications of G6PI in experimental models of rheumatoid arthritis. Arthritis Res. 2005, 7: 20-28. 10.1186/ar1476.
Article
CAS
Google Scholar
Gutcher I, Urich E, Wolter K, Prinz M, Becher B: Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation. Nat Immunol. 2006, 7: 946-953. 10.1038/ni1377.
Article
CAS
PubMed
Google Scholar
Drube S, Heink S, Walter S, Löhn T, Grusser M, Gerbaulet A, Berod L, Schons J, Dudeck A, Freitag J, Grotha S, Reich D, Rudeschko O, Norgauer J, Hartmann K, Roers A, Kamradt T: The receptor tyrosine kinase c-Kit controls IL-33 receptor signaling in mast cells. Blood. 2010, 115: 3899-3906. 10.1182/blood-2009-10-247411.
Article
CAS
PubMed
Google Scholar